Digital Transformation 2021 - Elekta’s Aftermarket Strategy: Using Connectivity for Equipment Reliability, Predictability and Better Patient Outcomes
Date2021-12-08
Deadline2021-12-08
VenueLIVE WEBINAR, Canada
KeywordsDigital Transformation; Radiotherapy; Device Connectivity
Topics/Call fo Papers
Who Should Attend?
Industry: Medical Device
Job Category: CXO, VP, Director, Manager
Job Function:
Service/Maintenance
Innovation/Strategy
Finance
Product Development
Product Management
Engineering
Service Operations
Engineering
IT
What You Will Learn
Learn how Elekta:
Uncovered the kinds of data required and expertise needed to deliver value
Identified key performance indicators (KPIs) used to measure results and value delivered to healthcare providers and patients
Used digital capabilities to successfully manage pandemic-induced challenges and the lessons learned that inform current operations
Developed a data architecture that both supports service and creates a digital thread to inform the entire organization
Is thinking about forward-looking strategies that consider new business models
Industry: Medical Device
Job Category: CXO, VP, Director, Manager
Job Function:
Service/Maintenance
Innovation/Strategy
Finance
Product Development
Product Management
Engineering
Service Operations
Engineering
IT
What You Will Learn
Learn how Elekta:
Uncovered the kinds of data required and expertise needed to deliver value
Identified key performance indicators (KPIs) used to measure results and value delivered to healthcare providers and patients
Used digital capabilities to successfully manage pandemic-induced challenges and the lessons learned that inform current operations
Developed a data architecture that both supports service and creates a digital thread to inform the entire organization
Is thinking about forward-looking strategies that consider new business models
Other CFPs
- Elekta’s Aftermarket Strategy: Using Connectivity for Equipment Reliability, Predictability and Better Patient Outcomes
- Imaging for Neuromuscular Disorders in Clinical Trials
- Preclinical Models for Microbiome Research in Oncology and Inflammatory Diseases
- Outsourcing Site Payments from the Sponsors’ Perspective
- Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge
Last modified: 2021-11-19 00:34:41